1 Photos and videos
Haresh Selvaskandan retweeted
9 Sep 2024
🚨 Exciting PhD Opportunity! 🚨
Join our cutting-edge research at the University of Leicester exploring mediators of loin pain in IgA nephropathy! #IgAN @IgAN_J @haresh11
le.ac.uk/study/research-degr… @IgAN_JBarratt
1
1
257
Haresh Selvaskandan retweeted
27 Sep 2024
Massive thank you to @uniofleicester, @IgAN_JBarratt, @haresh11, Lydia and Max for all the support. Sharing knowledge and learning from the experts
27 Sep 2024
The outstanding @ChloeECWil presenting exciting age-inclusive work on digital spatial profiling in IgAN/IgAVN at #ESPN2024, a @uniofleicester and @LivUni collaboration!
Looking forward to the full results (especially the complement-related findings!!)
@ESPNSociety @EspnYpnn
1
7
736
Haresh Selvaskandan retweeted
21 Aug 2023
Come join us in Brighton for the autumn SpR club meeting on 14-15th October…book on before it’s too late ! eventbrite.co.uk/e/spr-club-…
1
9
9
1,700
Haresh Selvaskandan retweeted
13 Jul 2023
We are excited to announce that the next SpR club Autumn meeting is in sunny (hopefully) Brighton. We will have some of the biggest names in research attending, a great opportunity for networking. Also fish and chips by the seaside is nice. eventbrite.co.uk/e/spr-club-…
2
9
12
3,645
Haresh Selvaskandan retweeted
13 May 2023
1/
A patient receiving his first-ever dose of IV Iron (ferumoxytol) suddenly develops diffuse face & trunk flushing, chest pain, myalgias, and anxiety.
Blood pressure is normal and lungs are clear.
You are called to the bedside to assess.
How likely is anaphylaxis?
27%
Very likely
26%
Somewhat likely
37%
Unlikely
10%
I dont know
14,560 votes • Final results
26
277
776
323,443
Haresh Selvaskandan retweeted
2 May 2023
Out today! The @KidneyBeamTrial protocol and baseline paper. A novel digital health intervention to support physical activity and self-management for ppl with CKD. Watch this space for the results- huge potential to impact care @sharleneuk @Kidney_Research bmcnephrol.biomedcentral.com…
6
16
53
8,032
Pneumocystis Jirovecii Pneumonia Prophylaxis by Dr. Dilushi Wijayaratne, MBBS MD (Medicine) MRCP(UK)
Check it out here 👉🏻 pubs.glomcon.org/pneumocysti…
#GlomCon
1
18
33
5,107
Haresh Selvaskandan retweeted
26 Apr 2023
An estimated 850 million people worldwide suffer from chronic kidney disease, and it is expected to become the fifth leading cause of death globally by 2040. Read more about the burden of CKD worldwide here: theisn.org/initiatives/globa…
#WorldKidneDay #KidneyDisease #GlobalIssue
11
30
2,713
Haresh Selvaskandan retweeted
26 Apr 2023
🔴Don't miss this broadcast next week, where @ShelleyZieroth @BonanadClara @AndrewFrankel1 & @drjamesburton explore emerging data and the changing landscape of medical management of hyperkalaemia ow.ly/4os150NRo9J
#CardioTwitter #MedEd
4
10
9
1,553
Haresh Selvaskandan retweeted
27 Jun 2021
Whenever you look to generalise from a small sample watch out for sampling bias (and all other sorts of bias that can easily creep in).
Extreme example from How to Lie with Statistics by Darrell Huff: amzn.to/3xZCWpo
18
414
1,563
Haresh Selvaskandan retweeted
11 Apr 2023
Come work with me !
7
10
3,271
Haresh Selvaskandan retweeted
5 Apr 2023
Not to be missed crash course for those embarking on a career as renal registrar
5 Apr 2023
For those starting or soon to start renal training!
Booking is now open for our 2nd renal crash course. For top tips for the first few months of the job please join us in Bristol in July. Sign up here 👇
eventbrite.co.uk/e/how-to-be…
@RenalSpRClub
@UKKidney
2
6
1,687
Haresh Selvaskandan retweeted
Sparsentan in patients with IgA nephropathy - treatment with sparsentan produced meaningful reduction in proteinuria compared with irbesartan in adults with IgA nephropathy. Published today. @TheLancet
7
20
1,924
Haresh Selvaskandan retweeted
18 Mar 2023
#nephworking #renalsprclub #dinnertime @CaesarOlGeezer @GlomerulaRajah @Javeria_Xx @nimmikins @alannaturtles @haresh11
6
19
1,951
Haresh Selvaskandan retweeted
10 Dec 2021
The temptation to use immunosuppression in crescentic IgAN is strong, but is it appropriate? Check out a case study: bit.ly/30ibCaW
#IgANephropathy
9
29
Haresh Selvaskandan retweeted
7 Sep 2021
This #eyeSCANDy image is an acellular scanning EM from a biopsy with membranous glomerulonephritis, stage I showing numerous small shallow depressions representing the site of immune complexes which were extracted corresponding to “pinholes” viewed on silver stain. #pathart
3
18
99
Haresh Selvaskandan retweeted
17 Aug 2021
📣 Guideline for review 📣
Draft UKKA guideline on Sodium-Glucose Co-transporter-2 (SGLT-2) Inhibition in Adults with #KidneyDisease is now available for review & comments:
renal.org/health-professiona…
#SGLT2 #CKD @AndrewFrankel1 @willkidney @drjamesburton
18
24
Haresh Selvaskandan retweeted
12 Aug 2021
Delighted to see this published. Very hopeful these data will lead to prioritised 3rd doses where needed. @EdjCarr has done a fantastic job driving this. Grateful to all in Leicester that allowed us to contribute data, especially @RBillany @SAdenwalla @haresh11 @KatherineHulll 1/
2
6
25
Haresh Selvaskandan retweeted
12 Aug 2021
VERY excited to announce registration is open for the Renal SpR club autumn meeting 2021! Sign up at: bit.ly/raspr_autumn. Great programme, great speakers - we can’t wait!
1
7
12